FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LOXAPINE by Actavis Pharma, Inc. under ANDA072206, indicating an updated indication or label for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)